Prof. Dr. Hans Ågren
University Hospital, Uppsala University, Uppsala, Schweden
Research in the subject of monoaminergenenic regulation mechanisms in depression aided by C1l marked 5-HTP and positron emission tomography (PET).
Dr. Beth J. Hoffmann
Laboratory of Cell Biology, National Institute of Mental Health
Research in the subject of cloning and gene expression of the serotonin transporter in the brain, which opens up a new path to the research into antidepressants.
Dr. Hans Förstl
Zentralinstitut für Seelische Gesundheit, Mannheim, Deutschland
Research in the subject of clinical and neuropathological correlation of depressive disorders in Alzheimer dementia.
Dr. Paul Linkowski, Ph.D.
Hôspital Erasme, Cliniques Universitaires de Bruxelles, Belgiques
Research in the subject of genetic influences on EEG parameters of sleep and the human Circadian rhythm.
l. to r.: Dr. H. Förstl, Prof. H. Helmchen, Dr. B. Hoffman, M. Rief,
Prof. H. Ǻgren, Dr. P. Linkowski
Prof. Dr. Norman E. Rosenthal
Dr. Thomas A. Wehr
National Institute of Mental Health, Bethesda, U.S.A.
Work on the nosological definition and causes of seasonal affective disorders and the development of light therapy.
M. Rief, Prof. B. Hess,
from above to below: Prof. N. Rosenthal / Prof. T.A. Wehr
Prof. Dr. Giorgio Racagni
Centro di Studio e Ricerca di Neurofaracologia, Università degli Studi di Milano, Italia
Work on the interaction of antidepressant treatment with a phosphorylation of MAP-2.
l. to r.: M. Rief, Prof. B. Hess, Prof. G. Racagni
Prof. Dr. Sofia Avissar
Prof. Dr. Gabriel Schreiber
Beer-Sheva Mental Health Center, Ben Gurion University of the Negev, Beer Sheva, Israel
Work on the interaction between anti-bipolar and antidepressant treatment with receptor-coupled G proteins.
l. to r.: Prof. G. Schreiber, Prof. S. Avisar,
Prof. Dr. R. M. Post
National Institute of Mental Health, Bethesda, Maryland, U.S.A.
Systematic clinical research into the detection of antidepressant efficacy and differential indication of carbamazepine as well as for a novel neuroadaptive conceptualisation of the intermittently progressive course of affective disorders.
Prof. Dr. G. Laakmann
Psychiatrische Klinik der Universität München, Deutschland
Work that is distinguished by accurate methodology and innovative approaches and that relates to the effect of psychopharmaceuticals onto the hormonal secretion of the frontal lobe of the hypophysis in non-psychiatric and in depressive patients.
Prof. Dr. H. Wachtel
Neuropsychopharmakologie, Schering AG, Berlin, Deutschland
Trailblazing work in the development of antidepressants via their effect on postsynaptic, intracellular regulation mechanisms.
l. to r.: Prof. G. Laakmann, Dr. H. Wachtel, Prof. B. Hess,
M. Rief, Prof. P. Kielholz, Prof. R. Post